Natural gas prices declined after failing to break resistance at $3.20-$3.25, driven by disappointing weather forecasts signaling lower demand next week. If prices drop below $3.10, they may test support near $3.00-$3.05. Meanwhile, oil prices surged due to escalating tensions between the US and Iran, with traders anticipating potential military action. WTI oil is attempting to break above $100.50-$101.00, aiming for $106.00-$106.50, while Brent oil tests resistance at $109.00-$109.50, potentially moving towards $114.50-$115.00 if it breaks through. These developments highlight geopolitical risks impacting energy markets ahead of the US midterm elections.
Natural gas and oil prices provide context for market conditions. For readers following US stocks, here is Pluang's market snapshot as of Oct 17, 2026 01:21 WIB: out of 150 US stocks, 44 rose and 104 fell. BlackBerry Limited (BB) traded at USD 8.11 with a 1-day change of -6.78%, Unity Software Inc (U) at USD 40.50 with -6.55%, and Lumen Technologies Inc (LUMN) at USD 4.56 with -6.37%.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
